Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism Daily treatment substantially reduced hypoglycemia over 13 weeks Jan 24, 2024
T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans? News and commentary from the endocrinology world Jan 23, 2024
Warning on Compounded GLP-1s; Ketoacidosis Deaths; Axon Stim for Diabetic Nerve Pain News and commentary from the endocrinology world Jan 16, 2024
FDA Clears Wegovy, Other GLP-1 Drugs of Suicidality Risk for Now Preliminary evaluation reassures, while the agency's review continues Jan 11, 2024
T1D Trial Paused After Deaths; Mounjaro Not Just Cosmetic; Late-Stage Hot Flash Win News and commentary from the endocrinology world Jan 09, 2024
No Increased Risk of Suicidal Ideation With GLP-1 Drugs Semaglutide shows lower risk of suicidal ideation than other obesity, diabetes drugs Jan 08, 2024
Maternal Type 1 Diabetes an Outsized Red Flag for Child Heart Defect Risk But don't ignore maternal overweight, obesity, and gestational diabetes, study says Jan 05, 2024
Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists Researchers looked at 7-year patient data Jan 04, 2024
In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective Risk of all-cause mortality, MAKE, and MACE were significantly reduced Jan 04, 2024
Lower Insulin Costs; Older Folks Want Obesity Meds Covered; Global Ozempic Woes News and commentary from the endocrinology world Jan 02, 2024
Bernie Sanders Has COVID; Global Fake Ozempic Problem; Nitazenes, the New Fentanyl? Health news and commentary from around the Web gathered by ΔΎΉΟΦ±²₯ staff Dec 29, 2023
Food as Diabetes Medicine? Maybe Not, Trial Suggests But intensive program did help boost engagement with healthcare Dec 26, 2023
Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealth News and commentary from the endocrinology world Dec 26, 2023
Deep Flaws in FDA's Device Oversight, and Patient Harm, Exposed in Lawsuits, Records "What is the threshold for the FDA to step in and do something?" Dec 24, 2023
Can a GLP-1 Agonist Improve Parkinson's Symptoms? A version of exenatide failed a phase II trial, but hinted at benefits in patients under 60 Dec 19, 2023
Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industry News and commentary from the endocrinology world Dec 19, 2023
Cannabis Exposure During Pregnancy; Tirzepatide Cessation and Weight Gain Also in TTHealthWatch: newer vaccine technologies in adults Dec 16, 2023 podcast
Weight-Loss Drug Overdoses; Record Number of Retracted Studies; Yoga and Cadavers Health news and commentary from around the Web gathered by ΔΎΉΟΦ±²₯ staff Dec 14, 2023
Stopping Tirzepatide Led to Weight Gain, Trial Shows But sustained treatment kept the pounds off Dec 13, 2023
New Diabetes Care Standards; Near 40% Ditch T2D Meds; Zepbound Hits Shelves News and commentary from the endocrinology world Dec 12, 2023
Metformin for Diabetes in Pregnancy: Maybe Not, Trial Says New trial complicates findings of previous studies Dec 12, 2023
GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patients Association strongest in patients with overweight, obesity Dec 07, 2023
Quick Albuminuria Reduction Key Factor in Finerenone's Efficacy 4-month UACR reduction mediated 84% of kidney treatment effect Dec 05, 2023
Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonists Pharmacists can intervene to educate, assist with cost, two studies suggest Dec 05, 2023
Pharmacists Can Spur Switch to Recommended Drugs for Diabetes Patients With CVD Intervention persuaded VA physicians to adjust care, helped lower HbA1c Dec 04, 2023
Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D News and commentary from the endocrinology world Dec 04, 2023
Orphan Drug Costs; Digital Devices for Diabetes Also in TTHealthWatch: smoking cessation benefits Dec 02, 2023 podcast
'Alexa, Titrate My Insulin': AI App Boosts Glycemic Control in Randomized Trial Voice-based app helped users to titrate basal insulin at home Dec 01, 2023
Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis News and commentary from the endocrinology world Nov 27, 2023
Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd News and commentary from the endocrinology world Nov 21, 2023
Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Events Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
Brolucizumab Noninferior to Aflibercept for Diabetic Macular Edema At a non-approved dose, the anti-VEGF drug had similar outcomes as rival Nov 17, 2023
Even Small Diabetes Distress Changes Clinically Important Researchers calculated cutoffs for significant DDS-17 scale changes Nov 15, 2023
One Copeptin Test More Accurate as Diagnostic for AVP Deficiency However, this test was more complicated, with more side effects, researchers note Nov 15, 2023
Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes News and commentary from the endocrinology world Nov 14, 2023
Diabetes Linked to Higher Colorectal Cancer Risk Associated risks highest in those with recent diagnoses Nov 14, 2023
Some Gliflozin Side Effects Worse in Autoimmune Rheumatic Disease Something to consider when prescribing SGLT-2 inhibitors Nov 14, 2023
AMA Supports Tighter Restrictions to Curb Pollution From Industrialized Farms Concentrated Animal Feeding Operations "may be a public health hazard," group says Nov 14, 2023
Tirzepatide Wins FDA Approval for Weight Loss Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
